Advertisement

Topics

Diabetes Drug, Exenatide, Shows Promise Against Parkinson's

08:08 EDT 4 Aug 2017 | Drugs.com

FRIDAY, Aug. 4, 2017 -- The diabetes drug exenatide (Byetta) may do double duty as a treatment for Parkinson's disease, a new study suggests. "This is a very promising finding, as the drug holds potential to affect the course of the disease itself,...

Original Article: Diabetes Drug, Exenatide, Shows Promise Against Parkinson's

NEXT ARTICLE

More From BioPortfolio on "Diabetes Drug, Exenatide, Shows Promise Against Parkinson's"

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...